Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)
ACHN.O on Nasdaq
7.70USD
14 Jun 2013
7.70USD
14 Jun 2013
Price Change (% chg)
$-0.02 (-0.26%)
$-0.02 (-0.26%)
Prev Close
$7.72
$7.72
Open
$7.68
$7.68
Day's High
$7.83
$7.83
Day's Low
$7.65
$7.65
Volume
556,422
556,422
Avg. Vol
1,021,463
1,021,463
52-wk High
$11.36
$11.36
52-wk Low
$5.42
$5.42
| LIOTTA DENNIS | Options Exercised: 0 | ||
| Trade Date: | Sunday, 20 Nov 2011 | Price: | 5.96 |
| Title: | Director | Shares Held: | 45,000 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 5,000 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 180 |
| Total Shares Held: | 100,554,623 |
| 3 Mo. Net Change: | 16,643,116 |
| # New Positions: | 30 |
| # Closed Positions: | 17 |
| # Increased Positions: | 104 |
| # Reduced Positions: | 54 |
| # Net Buyers: | 50 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
David Scheer |
60 | 2010 | Chairman of the Board |
Milind Deshpande |
55 | 2013 | President, Chief Executive Officer, Director |
Mary Kay Fenton |
48 | 2010 | Chief Financial Officer, Senior Vice President |
Gautam Shah |
56 | 2012 | Executive Vice President, Chief Compliance Officer |
David Apelian |
47 | 2013 | Executive Vice President, Chief Medical Officer |
Joseph Truitt |
48 | 2012 | Senior Vice President, Chief Commercial Officer |
Michael Kishbauch |
63 | 2013 | Director |
Jason Fisherman |
54 | 2000 | Independent Director |
Gary Frashier |
74 | 2008 | Independent Director |
Kurt Graves |
44 | 2012 | Independent Director |
Dennis Liotta |
2008 | Independent Director | |
Robert Van Nostrand |
55 | 2007 | Independent Director |
Nicole Vitullo |
53 | 2010 | Independent Director |

